Genfit SA  

(Public, EPA:GNFT)   Watch this stock  
Find more results for EPA:ALGFT
-0.23 (-0.76%)
Aug 29 - Close
EPA real-time data - Disclaimer
Currency in EUR
Range 29.52 - 30.47
52 week 5.07 - 36.64
Open 30.19
Vol / Avg. 275,651.00/277,204.00
Mkt cap 699.82M
P/E     -
Div/yield     -
EPS -0.66
Shares 23.37M
Beta     -
Inst. own     -

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -153.70% -212.02%
Operating margin -158.05% -176.19%
EBITD margin - -165.87%
Return on average assets -29.70% -47.99%
Return on average equity -58.30% -120.92%
Employees 78 -
CDP Score - -


885 Avenue Eugene Avinee, Parc Eurasante
LOOS, 59120
+33-3-20164000 (Phone)
+33-3-20164001 (Fax)

Website links


Genfit SA is a France-based biopharmaceutical company that specializes in the development of medicines for the prevention and treatment of diabetes and related disorders. It develops diagnostic solution for cardiometabolic and neurodegenerative diseases. It focuses on a number of disorders, including diabetes, vascular inflammation, atherosclerosis and others. The Company works in collaboration with such pharmaceutical companies as Sanofi-Aventis, Solvay Group, Kowa Pharmaceutical, UCB Pharma, Pierre Fabre, Pfizer and Servier Laboratories. It operates wholly owned subsidiaries, such as Genfit Corporation, located in Cambridge, the United States and Genfit Pharmaceuticals SAS. As of December 31, 2010, Holding Biotech Avenir held a 24.15% stake in the Company´┐Żs shareholdings.

Officers and directors

Xavier Guille Des Buttes Chairman of the Supervisory Board
Jean-Francois Mouney Chairman of the Management Board, Chief Executive Officer
Charles Woler Vice Chairman of the Supervisory Board
Raphael Darteil Chief Operating Officer, Executive Vice President, Member of the Management Board
Nathalie Huitorel Executive Vice President of Finance, Member of the Management Board
Bart Staels President of the Scientific Advisory Board, Member of the Management Board
Frederic Lobez Member of the Supervisory Board, Representative of Universite de Lille II
Philippe Moons Member of the Supervisory Board, Representative of Finorpa
Florence Sejourne Member of the Supervisory Board, Representative of Biotech Avenir
Philippe Traisnel MBA Independent Supervisory Board, Representative of CM-CIC Capital Finance